Fidia Pharma USA Inc
Kevin Boe has extensive work experience in the pharmaceutical industry. Kevin currently holds the position of National Sales Director at Fidia Pharma USA Inc, a role they have held since March 2020. Prior to this, they worked as a District Sales Manager at Alfasigma USA from April 2019 to March 2020. From September 2018 to April 2019, they held the role of Key Account Manager at Fidia Pharma USA Inc. Earlier in their career, they gained valuable experience at Sanofi Biosurgery as a Biotech/Pharma Sales leadership, Performance Management & Training Professional, leading a team of 9 and achieving high rankings in the district. Kevin also worked at Sanofi in various positions, including CV-Regional Training Manager and CV & Specialty Care Training Manager, where they were responsible for training and skills development for the field force. Additionally, they held roles at Sanofi-Aventis as a Specialty Sales Professional and District Sales Manager, and at Novartis as a District Sales Manager.
Kevin Boe attended North Dakota State University from 1986 to 1991. Kevin obtained a Bachelor of Science degree in Business and Economics during this time.
This person is not in any offices
Fidia Pharma USA Inc
Fidia Pharma USA Inc is a wholly-owned subsidiary of the Italian pharmaceutical manufacturer Fidia Farmaceutici S.p.A., an established leader in the hyaluronic acid (HA) market segment. Fidia Pharma USA is focused on continually expanding Fidia’s position in the U.S. and Canadian market, while upholding the company's mission to provide consumers with innovative products that offer quality, safety and performance, establishing a sound strategic presence of Fidia in the US consistently with the Company's mission and strategy pillars. Drawing on the strengths of the parent company, Fidia Pharma USA product portfolio focuses primarily on therapeutic areas such as joint healthcare and tissue repair. Fidia Pharma USA Inc is headquartered in Parsippany, NJ.